The Consumer Electronics Show (CES) 2026 in Las Vegas, USA, has once again become a launchpad for ambitious health tech. Among the standout announcements is Withings' latest evolution in home health monitoring: the Body Scan 2. Priced at a premium USD 599.95 and positioned as a "longevity station," this device aims to transcend the basic functions of a smart scale by integrating advanced sensors and AI-driven analytics typically found in high-end wearables. This article delves into the specifications, new features, and the potential impact of this comprehensive health-tracking platform.
Key Specifications & Features of Withings Body Scan 2
- Price: USD 599.95
- Announcement Date: January 2026 (CES 2026)
- Expected Release: Q2 2026
- Key New Features:
- AI-based arterial hypertension risk detection (no cuff required)
- Glycemic dysregulation/prediabetes risk detection
- Impedance Cardiography (ICG) for heart health metrics
- 6-lead ECG
- Pulse Wave Velocity measurement for arterial stiffness
- "Health Trajectory" scoring system
- Design: Smart scale with retractable handle containing electrodes and a display screen.
- Claimed Metrics: Over 60 biomarkers.
- Regulatory Note: Some advanced health features pending FDA clearance.
A New Class of Health Monitor
The Withings Body Scan 2 represents a significant leap from its predecessor and conventional smart scales. Its defining physical feature is a retractable handle equipped with electrodes and a small screen. This design allows the device to take measurements from both the hands and feet, creating a more complete bioelectrical impedance analysis of the entire body, rather than just the lower limbs. This setup is crucial for the scale's claim of measuring over 60 biomarkers, moving far beyond simple weight and body fat percentage readings.
AI-Powered Early Warning System
The most groundbreaking feature announced is the AI-based detection of arterial hypertension risk without the need for a traditional blood pressure cuff. By analyzing data from its multiple sensors, the device's algorithm can flag potential issues, offering users an early warning. Similarly, it can detect signs of glycemic dysregulation, providing a potential early alert for prediabetes. These features position the Body Scan 2 as a proactive tool for long-term health trajectory monitoring, complementing its suite of standard metrics like muscle mass, water percentage, and visceral fat.
Advanced Cardiac and Vascular Insights
Leveraging its handle-and-footplate sensor array, the Body Scan 2 employs Impedance Cardiography (ICG) and a six-lead ECG. The ICG technology allows it to assess aspects of heart health, such as stroke volume and cardiac output. Furthermore, by measuring pulse wave velocity—the speed at which blood travels from the torso to the hands and feet—the device can estimate arterial stiffness, a key indicator of cardiovascular health. This brings hypertension monitoring and detailed ECG readings, features popularized by smartwatches, into a daily weigh-in routine.
Price and Positioning in the Market
With a price tag of USD 599.95, the Body Scan 2 enters the market as a premium, niche product. It is USD 100 more expensive than the first-generation Body Scan and significantly pricier than most mainstream smart scales, which often cost under USD 100. Withings is clearly targeting consumers who are deeply invested in comprehensive, long-term health data aggregation and are willing to pay for advanced analytics and early risk detection that blur the line between consumer wellness and clinical-grade monitoring.
Price Comparison
| Product | Price (USD) | Key Differentiator |
|---|---|---|
| Withings Body Scan 2 | 599.95 | AI hypertension detection, ICG, 6-lead ECG, handle with screen. |
| Withings Body Scan (1st Gen) | 399.95 | Basic handle for upper body metrics, fewer advanced features. |
| Typical Smart Scale | 50 - 150 | Weight, body fat %, muscle mass, BMI via foot-to-foot impedance. |
Limitations and Important Considerations
It is critical to emphasize that the Body Scan 2 is not a medical device. Withings notes that features like the hypertension detection are pending FDA clearance. The company and early reports stress that the scale should not be used as a substitute for professional medical diagnosis, consultation, or medical-grade equipment. Its role is to provide trends, insights, and early warnings that empower users to seek timely professional advice. The accuracy of its advanced biometrics, especially compared to clinical standards, will be a key point of scrutiny upon its release.
Availability and Final Thoughts
The Withings Body Scan 2 is expected to become available for purchase in the second quarter of 2026. Its launch at CES 2026 signals a growing trend of integrating sophisticated health diagnostics into everyday home devices. For the health-conscious tech enthusiast seeking a centralized dashboard for a wide array of body metrics, the Body Scan 2 presents a compelling, if expensive, proposition. Its success will ultimately depend on the proven accuracy of its novel features and its ability to deliver meaningful, actionable health insights that justify its substantial cost.